Hepatobiliary Surgery

In HPB surgery, multiple factors such as treatment with antiplatelet/anticoagulant therapies as well as resection size and tissue quality can impact intraoperative blood loss1.  The extent of blood loss impacts patient morbidity and mortality but may also present risk for longer term oncological outcomes2. In pancreatic surgery, the most serious complication is pancreatic leakage in the form of post-operative pancreatic fistula. Baxter’s portfolio of solutions can help promote better outcomes in these challenging procedures.

Key Procedures

Each HPB procedure provides unique challenges that can cause complications for the healing process. Here are a few examples:

Image of FLOSEAL in applicator in a gloved hand along with the FLOSEAL logo next to it

FLOSEAL in Liver Resection

FLOSEAL, Baxter's flowable hemostat, is highly effective to achieve hemostasis in deep and irregular transection cavities during both open and MIS liver resection procedures. FLOSEAL, provides effective, fast hemostasis in major hepatic surgery to remove primary or metastatic tumors, controlling mild to severe bleeding from the liver edge, even in patients with cirrhotic livers5. A variety of applicator tips and cannulas are available to facilitate FLOSEAL’s application, including sites that are difficult to access.

Learn more about FLOSEAL >

Image of Hemopatch product and logo

HEMOPATCH in Liver Resection

HEMOPATCH, Baxter’s collagen pad with NHS-PEG adhesive coating, provides effective hemostasis in open and minimally invasive liver resections with largely plane transection surfaces6. Extensive vascular exposure during liver resections can increase the risk of bleeding and fistula formation.  HEMOPATCH can decrease the biliary and hemorrhagic complications in liver applications, providing a strong mechanical bolster to seal even cauterized tissue7. Surgeon preferred for its flexibility/pliability and tissue adherence, HEMOPATCH handles with ease in MIS applications8.

Learn more about HEMOPATCH >

Whipple & Distal Pancreatectomy

Postoperative pancreatic fistula (POPF) is the most common major complication after pancreatectomy and it is a potentially serious and life-threatening complication that may lead to prolonged hospital stay and increased costs9. HEMOPATCH, Baxter’s ready to use advanced patch, provides effective sealing with mechanical strength that may decrease both the incidence and severity of POPFs in both Whipple and distal pancreatectomy procedures10,11.

Learn more about HEMOPATCH >

Portfolio of Products

Baxter takes safety of our products and patients very seriously. If you would like to report an adverse event with Baxter drugs (e.g. Tisseel, Artiss, …), you can contact Baxter directly: [email protected] or you can report it via authority’s website:

For Belgium: www.eenbijwerkingmelden.be or www.notifieruneffetindesirable.be

For Luxembourg: www.guichet.lu/pharmacovigilance

Any medical device product quality complaints (including medical device adverse incidents) relating to Baxter products should be sent to EMEA SHS Complaints Intake [email protected]